Related Experiment Video

Updated: May 20, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Quantitative structure-activity relationship analysis of a series of human renal organic anion transporter inhibitors

Yuhui Wei1, Lili Xi, Xiaojun Yao

  • 1Department of Pharmacy, Lanzhou University First Hospital, Lanzhou, China.

Archiv Der Pharmazie
|July 26, 2012
PubMed

Insights

This study developed a quantitative structure-activity relationship (QSAR) model to predict organic anion transporter (OAT) inhibition. The model aids in screening new drug candidates for potential interactions with OAT1 and OAT3 transporters.

Area of Science:

  • Pharmacology
  • Medicinal Chemistry
  • Computational Chemistry

Background:

  • Organic anion transporters (OATs) are crucial for eliminating xenobiotics, drugs, and metabolites.
  • Drug-OAT interactions can lead to reduced clearance, prolonged action, and adverse clinical outcomes.
  • Assessing OAT inhibitory activity is vital during drug development and co-administration.

Purpose of the Study:

  • To analyze the relationship between chemical structures and their inhibitory activity against human OAT1 (hOAT1) and OAT3 (hOAT3).
  • To develop a robust quantitative structure-activity relationship (QSAR) model for predicting hOAT1 and hOAT3 inhibition.
  • To establish a tool for screening potential hOAT1 and hOAT3 inhibitors.

Main Methods:

  • Quantitative structure-activity relationship (QSAR) modeling.
  • Utilized a dataset of 45 chemicals and their inhibitory activities against hOAT1 and hOAT3.
  • Employed genetic algorithms and multiple linear regression for model development.

Main Results:

  • Developed predictive QSAR models for hOAT1 and hOAT3 inhibition.
  • Strictly evaluated the predictive power and defined the applicability domain of the models.
  • The models demonstrated robustness and satisfactory performance.

Conclusions:

  • The developed QSAR models offer a feasible and effective method for screening hOAT1 and hOAT3 inhibitors.
  • This approach can aid in predicting and mitigating drug-drug interactions involving OATs.
  • Facilitates safer drug development by identifying potential transporter liabilities early.

More Related Videos

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
Drug Elimination by Renal Route: Tubular Secretion01:15

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Renal Drug Excretion: Tubular Reabsorption01:25

Renal Drug Excretion: Tubular Reabsorption

Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...